Mon, 26-Sep-2022
Wednesday 27 Nov 2019 , 9:05 am

US Medical Innovations Receives FDA 510(k) Clearance for the Canady Plasma Smart XL-1000 Generator

The GIMMS Smart Operating System includes pre-loaded Surgical Apps, data collection, built-in safety features and the integration of other surgical devices in the operating room.
By SIN Bureau
Share at:

US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI) announced today the U.S. Food And Drug Administration (FDA) 510(k) clearance (#K192124) to market and sell the Canady Plasma Smart XL-1000 Electrosurgical Generator (CPSXEG) with accessories.

CANADY PLASMA XL-1000 (Source: US Medical Innovations, LLC (USMI) Website)

The CPSXEG combines with a high frequency voltage to electrically enhanced plasma gas (i.e. Argon) to produce a plasma gas stream. The unit provides various plasma modes including Canady Hybrid Plasma, Argon Plasma as well as standard cutting and coagulation modes.

The Canady Plasma SMART XL-1000 Electrosurgical Generator is an operating system, the GRAPHICAL INTEGRATED MAGEMENT SURGICAL SYSTEM™ (GIMSS). GIMMS was developed by USMI’s engineering team in the USA. The GIMMS Smart Operating System includes pre-loaded Surgical Apps, data collection, built-in safety features and the integration of other surgical devices in the operating room.

The user can decide on the specific surgical application by touching the particular APP screen (i.e. General Surgery, Robotics, Orthopedics, Endoscopy, Gynecology, Transplantation, Plastic and Cosmetic Surgery, Trauma, Cardiology, Urology, Surgical Oncology, Pediatrics). Once the device is activated, name of physician, device recognition and safety features, power in watts, gas flow rate, gas volume, and energy mode are displayed on the monitor. The CPSXEG also has the capability to download secure procedural data into the electronic medical record of the patient.

The Canady Plasma SMART XL-1000 Electrosurgical Generator was developed by Jerome Canady, M.D. Chief Science Officer and Taisen Zhuang, PhD VP Research & Development and the engineering team at USMI (Takoma Park, Md.). The CPSXEG generator will be manufactured at Canady Biotechnology (Takoma, Park, Md.) USA a subsidiary of USPI and scheduled for shipment in the U.S. and Middle East in December 2019.

Dr. Canady (CEO, USMI and Chairman of USPI’s family of companies) commented, “The Canady Plasma® SMART XL-1000 Electrosurgical Generator with Accessories is the next generation of Electrosurgical Generators. USMI is the first to transform an electrosurgical generator from Analog to Smart technology. The new generator is integrated with USMI’s patented Canady Hybrid Plasma (CHP) technology that is used to simultaneously cut, coagulate, and ablate biological tissue during surgery. Unlike traditional plasma coagulation and standard electrosurgical devices, CHP technology creates a plasma gas energy beam that cuts and coagulates to a minimal invasive depth as low as 0.1 mm while maintaining a tissue temperature of approximately 98°F (37°C) or less. The beam can coagulate blood vessels up to 4mm. CPSXEG via GIMSS can provide a simple solution to a complex Operating Room (OR) when integrated with the Canady SMART OR Stealth Integration System including surgical devices for a variety of surgical applications (i.e. Robotic, Advanced Endoscopic, Mini-invasive, Complex surgical procedures, Cosmetics, Plastic Reconstruction, Burns, and Trauma).”




Neha Mule

Neha writes articles on sectors including medicine, food, materials, and science & technology. A qualified statistician, she has the ability to observe and analyze the trends in global markets and write compelling articles that help CXOs in decision making. She is a bookworm and loves to read fiction, lifestyle, science and technology. Neha comes with 6 years of experience in content writing and editing that involves blog writing, preparation of study materials and OERs.

More from Neha Mule

Related News